JP Morgan Maintains Overweight on Calix, Lowers Price Target to $58

Benzinga Newsdesk www.benzinga.com Negative 84.5%

Neg 84.5% Neu 0% Pos 0%

JP Morgan analyst Samik Chatterjee maintains Calix (NYSE:CALX) with a Overweight and lowers the price target from $65 to $58.